Feng-Di Lung

Title: The Innovative Contributions of Inventor Feng-Di Lung

Introduction

Feng-Di Lung, located in Taichung, Taiwan, is an accomplished inventor with a notable portfolio of six patents. His work prominently addresses critical issues in cancer treatment and prevention, utilizing advanced techniques in biotechnology.

Latest Patents

Among his latest innovations, Feng-Di Lung developed peptides for cancer treatment, which focus on the inhibition of cancer growth, invasion, and metastasis by employing peptide fragments derived from the SLIT2 protein. Additionally, he has created a patent on a THLW peptide, characterized by its specific amino acid sequence, which serves as a biomarker for oral and cervical cancers, particularly in relation to Human Papilloma Virus (HPV) infections. This THLW peptide and its corresponding antibodies can effectively be utilized to assess the risk of developing various cancers in individuals.

Career Highlights

Feng-Di Lung has collaborated with significant institutions, including Tunghai University and the Government of the United States of America, representing the Department of Health and Human Services. His work exemplifies a strong commitment to advancing medical technology and improving patient outcomes.

Collaborations

Throughout his career, Feng-Di Lung has worked alongside esteemed colleagues such as Peter P Roller and C Richter King. These collaborations have undoubtedly enriched his research and contributed to the successful development of his innovative patents.

Conclusion

Feng-Di Lung's contributions to cancer research through his patents reflect his dedication to innovation and the potential to save lives. His discoveries in the field of peptides and cancer treatment are paving the way for future advancements in healthcare and biotechnology.